Vivos: Non-Surgical Solution for Obstructive Sleep Apnea | VVOS Our treatment employs a multidisciplinary treatment plan that uses noninvasive, cost-effective oral appliance technology prescribed by trained dentists and medical professionals to treat dentofacial abnormalities and or mild, moderate, and severe OSA and snoring This revolutionary treatment is called The Vivos Method
Vivos Therapeutics Receives First Ever FDA 510(k) Clearance for Oral . . . The Vivos Method includes treatment regimens that employ the proprietary Vivos Complete Airway Repositioning and or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and or palate
Obstructive Sleep Apnea Patients - Vivos If you have NOT yet been diagnosed with OSA, complete our self-assessment survey to be connected with a Vivos-trained provider in your area Find out now if Vivos is right for you
Vivos Therapeutics Receives FDA 510(k) Clearance of its Flagship DNA . . . The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild-to-moderate OSA, such as lowering Apnea Hypopnea Index scores Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full . . . The three Vivos CARE devices open airway space and may significantly reduce symptoms and conditions associated with mild-to-severe OSA, such as lowering Apnea Hypopnea Index scores Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada Transaction brings OSA diagnostic revenue to Vivos, plus Vivos’ highly effective OSA treatment options to thousands of potential patients in the greater Las Vegas area Transaction also completes Vivos’ business model pivot to target high patient volume centers and higher margin revenues
Vivos Therapeutics to Begin Clinical Trial at Stanford Medicine The Vivos Method represents the first clinically effective nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution for treating mild to moderate OSA in adults It has proven effective in approximately 40,000 patients treated worldwide by more than 1,800 trained dentists
Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for . . . LITTLETON, Colo , Oct 08, 2024 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related breathing disorders, including obstructive sleep apnea (OSA) in adults
Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to . . . The Vivos Method (comprised of Vivos’ Complete Airway Repositioning and or Expansion (CARE) and other oral appliance therapy combined with adjunctive therapies) represents the first clinically effective nonsurgical, removable, nonpharmaceutical, and cost-effective solution for treating mild to severe OSA in adults and moderate to severe OSA